The FDA’s Center for Drug Evaluation and Research approved 21 new molecular entities (NMEs) in 2008, up from 16 the year before. Three biologic license applications (BLAs) were approved, compared to two in 2007. Three of the NMEs and one of the BLAs were delayed approvals. The drugs with the fastest approval times tend to […]
The new year began with much of the same disheartening economic news as the previous year’s end, including escalating unemployment rates, subdued retail sales, corporate profit warnings and unrelenting liquidity concerns in the banking sector. For the first two trading weeks of the year, the Dow Jones Industrial Average, S&P 500 and NASDAQ declined 8.3%, […]
Portability has long been touted as a powerful capability of molecular spectroscopy systems, and in the last couple of years portable molecular spectroscopy has gained momentum, especially with the introduction of portable Raman systems. In fact, a number of new products have recently been introduced to the market (see IBO 3/15/08). Among the advantages of […]
Company Announcements Cell Projects entered into a commercial license and development agreement in October 2008 with Queen’s University in Canada, covering several new electroporation technologies for adherent and in situ cell electroporation. Fluxion Biosciences named two new distributors: Labtech International for the UK, Ireland and France, and Westburg BV for Belgium, The Netherlands, Luxembourg, Denmark, […]
The US Consumer Products Safety Commission (CPSC) has delayed by one year the enforcement of certain requirements of the Consumer Product Safety Improvement Act (CPSIA), which were to take effect on February 10. The CPSIA implements new certification and testing requirements for products, including toys and other products for children under 12. The limits on […]
Company Announcements In a management buyout, Harvard Bioscience sold its Union Biometrica division, the remaining portion of its Capital Equipment business, in October 2008 for $1 in cash, the assumption of certain liabilities and an earn-out. Harvard Bioscience named Thomas McNaughton, most recently CFO of Tivoli Audio, CFO in November 2008. Jock Fyfe Lennox, senior […]
Marlborough, MA 1/26/09; San Diego, CA and Ann Arbor, MI 1/26/09; San Diego, CA 1/27/08; San Diego, CA 1/28/09—Sequenom has terminated its bid for diagnostics firm EXACT Sciences (see IBO 1/15/09), following Genzyme’s acquisition of certain intellectual property assets held by EXACT related to the fields of prenatal and reproductive health and three million shares […]
Palo Alto, CA 1/16/09—Varian has announced that its expects fiscal year 2009 first-quarter sales, for the quarter ended January 2, to be $205–$210 million, compared to revenues of $237.4 million for the same period a year ago. “Although we entered the first quarter with a strong backlog for these products and saw solid orders during […]
Company Announcements Empire Genomics will develop locus-specific DNA probes for One Cell Systems for slide-based FISH applications. Empire will also comarket One Cell’s synthetic oligonucleotide probes for chromosome enumeration. In November 2008, QIAGEN licensed certain methylation technologies from OncoMethylome Sciences for use in its EpiTect product line. Five new members joined the RNAi Global Initiative, […]
The European Parliament has approved legislation regulating the use of pesticides. The law bans certain highly toxic chemicals in pesticides and creates criteria for the use of other substances. The EU will create a list of approved “active substances,” consisting of chemicals that can be used in pesticides. Based on an assessment by the Swedish […]
Pay Invoice
Latest Blogs
-
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
October 24, 2024 5:17 pm
-
M&A Activity in the Analytical Instrumentation and Lab Tools Market. 2021-2023
September 30, 2024 1:32 pm
-
Survey Results: Life Science Labs and Sustainable Consumables
August 30, 2024 7:43 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
